Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (6): 1102-1107. doi: 10.19723/j.issn.1671-167X.2018.06.029
• Article • Previous Articles Next Articles
Xiao-hui ZHANG1,Xue-rong DENG1,Fan Li2,Ying ZHU3,Zhuo-li ZHANG1,△()
CLC Number:
[1] |
Tay SH, Mak A . Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus:time to untie the Gordian knot[J]. Rheumatology (Oxford), 2017,56(Suppl1):i14-i23.
doi: 10.1093/rheumatology/kex017 pmid: 28339930 |
[2] |
Shankar J, Banfield J . Posterior reversible encephalopathy syndrome: a review[J]. Can Assoc Radiol J, 2017,68(2):147-153.
doi: 10.1016/j.carj.2016.08.005 pmid: 28131335 |
[3] |
Toledano M, Fugate JE . Posterior reversible encephalopathy in the intensive care unit[J]. Handb Clin Neurol, 2017,141:467-483.
doi: 10.1016/B978-0-444-63599-0.00026-0 |
[4] |
Fugate JE, Rabinstein AA . Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions[J]. Lancet Neurol, 2015,14(9):914-925.
doi: 10.1016/S1474-4422(15)00111-8 pmid: 26184985 |
[5] |
Datar S, Singh TD, Fugate JE , et al. Albuminocytologic dissociation in posterior reversible encephalopathy syndrome[J]. Mayo Clin Proc, 2015,90(10):1366-1371.
doi: 10.1016/j.mayocp.2015.07.018 pmid: 26349950 |
[6] |
Lee VH, Wijdicks EF, Manno EM , et al. Clinical spectrum of reversible posterior leukoencephalopathy syndrome[J]. Arch Neurol, 2008,65(2):205-210.
doi: 10.1016/S0887-8994(01)00265-X pmid: 18268188 |
[7] |
Varaprasad IR, Agrawal S, Prabu VN , et al. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus[J]. J Rheumatol, 2011,38(8):1607-1611.
doi: 10.1097/RHU.0b013e3182a21ffd pmid: 23965484 |
[8] | Casey SO, Sampaio RC, Michel E , et al Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion re-covery MR imaging in the detection of cortical and subcortical lesions[J]. Am J Neuroradiol, 2000,21(7):1199-1206. |
[9] |
Magnano MD, Bush TM, Herrera I , et al. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus[J]. Semin Arthritis Rheum, 2006,35(6):396-402.
doi: 10.1016/j.semarthrit.2006.01.002 pmid: 16765717 |
[10] |
Brady E, Parikh NS, Navi BB , et al. The imaging spectrum of posterior reversible encephalopathy syndrome: a pictorial review[J]. Clin Imaging, 2018,47:80-89.
doi: 10.1016/j.clinimag.2017.08.008 pmid: 28910681 |
[11] |
Bartynski WS, Boardman JF . Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome[J]. Am J Neuroradiol, 2007,28(7):1320-1327.
doi: 10.3174/ajnr.A0549 |
[12] |
McKinney AM, Short J, Truwit CL , et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings[J]. Am J Roentgenol, 2007,189(4):904-912.
doi: 10.2214/AJR.07.2024 pmid: 17885064 |
[13] |
Gao B, Lyu C, Lerner A , et al. Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years[J]. J Neurol Neurosurg Psychiatry, 2018,89(1):14-20.
doi: 10.1136/jnnp-2017-316225 pmid: 28794149 |
[14] |
Gatla N, Annapureddy N, Sequeira W , et al Posterior reversible encephalopathy syndrome in systemic lupus erythematosus[J]. J Clin Rheumatol, 2013,19(6):334-340.
doi: 10.1097/RHU.0b013e3182a21ffd pmid: 23965484 |
[15] |
Junewar V, Verma R, Sankhwar PL , et al. Neuroimaging features and predictors of outcome in eclamptic encephalopathy: a prospective observational study[J]. Am J Neuroradiol, 2014,35(9):1728-1734.
doi: 10.3174/ajnr.A3923 pmid: 24722310 |
[16] |
Karia SJ, Rykken JB , McKinney ZJ, et al. Utility and significance of gadolinium-based contrast enhancement in posterior reversible encephalopathy syndrome[J]. Am J Neuroradiol, 2016,37(3):415-422.
doi: 10.3174/ajnr.A4563 pmid: 26564441 |
[17] |
Covarrubias DJ, Luetmer PH, Campeau NG . Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images[J]. Am J Neuroradiol, 2002,23(6):1038-1048.
doi: 10.1055/s-2002-32034 pmid: 12063238 |
[18] |
Schweitzer AD, Parikh NS, Askin G , et al. Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome[J]. Neuroradiology, 2017,59(4):379-386.
doi: 10.1007/s00234-017-1815-1 pmid: 28289809 |
[19] |
Rabinstein AA, Mandrekar J, Merrell R , et al. Blood pressure fluctuations in posterior reversible encephalopathy syndrome[J]. J Stroke Cerebrovasc Dis, 2012,21(4):254-258.
doi: 10.1016/j.jstrokecerebrovasdis.2011.03.011 pmid: 21536456 |
[20] |
van Beek AH, Claassen JA, Rikkert MG , et al. Cerebral auto-regulation: an overview of current concepts and methodology with special focus on the elderly[J]. J Cereb Blood Flow Metab, 2008,28(6):1071-1085.
doi: 10.1038/jcbfm.2008.13 pmid: 18349877 |
[21] |
Gao B, Lerner A, Law M . The Clinical outcome of posterior reversible encephalopathy syndrome[J]. Am J Neuroradiol, 2016,37(9):E55-E56.
doi: 10.3174/ajnr.A4853 |
[22] |
Sha Z, Moran BP , McKinney AMT, et al. Seizure outcomes of posterior reversible encephalopathy syndrome and correlations with electroencephalographic changes[J]. Epilepsy Behav, 2015,48:70-74.
doi: 10.1016/j.yebeh.2015.05.027 pmid: 26071927 |
[23] |
Legriel S, Schraub O, Azoulay E , et al. Determinants of recovery from severe posterior reversible encephalopathy syndrome[J]. PLoS One, 2012,7(9):e44534.
doi: 10.1371/journal.pone.0044534 pmid: 23024751 |
[24] |
Shaharir SS, Remli R, Marwan AA , et al. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: pooled analysis of the literature reviews and report of six new cases[J]. Lupus, 2013,22(5):492-496.
doi: 10.1177/0961203313478303 pmid: 23435619 |
[25] |
Damrongpipatkul U, Oranratanachai K, Kasitanon N , et al. Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study[J]. Clin Rheumatol, 2018,37(3):691-702.
doi: 10.1007/s10067-017-3892-2 pmid: 29103182 |
[26] |
Jung SM, Moon SJ, Kwok SK , et al. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome[J]. Lupus, 2013,22(9):885-891.
doi: 10.1177/0961203313496341 pmid: 23846231 |
[27] |
Lai CC, Chen WS, Chang YS , et al. Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus[J]. Arthritis Care Res (Hoboken), 2013,65(11):1766-1774.
doi: 10.1002/acr.22047 pmid: 23687067 |
[28] |
Budhoo A, Mody GM . The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus[J]. Clin Rheumatol, 2015,34(12):2127-2134.
doi: 10.1007/s10067-015-3055-2 pmid: 26298534 |
[29] |
Ferreira TS, Reis F, Appenzeller S . Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus[J]. Lupus, 2016,25(12):1369-1376.
doi: 10.1177/0961203316643598 pmid: 27084028 |
[30] |
Merayo-Chalico J, Apodaca E, Barrera-Vargas A , et al. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study[J]. J Neurol Neurosurg Psychiatry, 2016,87(3):287-294.
doi: 10.1136/jnnp-2014-310145 pmid: 25804426 |
[31] |
Ishimori ML, Pressman BD, Wallace DJ , et al. Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE[J]. Lupus, 2007,16(6):436-443.
doi: 10.1177/0961203307078682 pmid: 17664235 |
[32] |
Barber CE, Leclerc R, Gladman DD , et al. Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus[J]. Semin Arthritis Rheum, 2011,41(3):353-363.
doi: 10.1016/j.semarthrit.2011.07.001 pmid: 21868061 |
[1] | Jia-yi TIAN,Xia ZHANG,Gong CHENG,Qing-hong LIU,Shi-yang WANG,Jing HE. Serum interleukin-2 receptor α as a clinical biomarker in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1083-1087. |
[2] | Jian-mei ZOU,Li-jun WU,Cai-nan LUO,Ya-mei SHI,Xue WU. Relationship of serum 25- hydroxy vitamin D and systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 938-941. |
[3] | Zheng-fang LI,Xue WU,Li-jun WU,Cai-nan LUO,Ya-mei SHI,Yan ZHONG,Xiao-mei CHEN,Xin-yan MENG. Clinical features of patients with Rhupus syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 933-937. |
[4] | XIA Fang-fang,LU Fu-ai,LV Hui-min,YANG Guo-an,LIU Yuan. Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 266-272. |
[5] | Yue HOU,Xu-tong ZHAO,Zhi-ying XIE,Yun YUAN,Zhao-xia WANG. Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes / myoclonus epilepsy with ragged-red fibers /Leigh overlap syndrome caused by mitochondrial DNA 8344A>G mutation [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 851-855. |
[6] | Qian GUO, Xiao-xu MA, Hui GAO, Lian-jie SHI, Yu-chao ZHONG, Lin-feng XIE, Miao SHAO, Xue-wu ZHANG. Association of Semaphorin 3A with thrombocytopenia in systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 892-896. |
[7] | Yan GENG,Bo-rui LI,Zhuo-li ZHANG. Musculoskeletal ultrasound findings of symptomatic joints in patients with systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 163-168. |
[8] | Ying-ni LI,Xiao-hong XIANG,Jing ZHAO,Yun LI,Feng SUN,Hong-yan WANG,Ru-lin JIA,Fan-lei HU. Significance of anti-carbamylated fibrinogen antibodies in systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1019-1024. |
[9] | Yu-hua WANG,Guo-hua ZHANG,Ling-ling ZHANG,Jun-li LUO,Lan GAO. Adrenal hemorrhage in a patient with systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1178-1181. |
[10] | Fan YANG,Yun-shan ZHOU,Yuan JIA. Systemic lupus erythematosus with acquired hemophilia A: a case report [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1108-1111. |
[11] | Shuang LIU,Yu-long GUO,Jing-yi YANG,Wei WANG,Jian XU. Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1014-1021. |
[12] | Jiao YANG,Hai-hong YAO,Xiao-dong MO,Zeng LUO,yang-jin Bai-ma. Clinical and immunological characteristics of patients with systemic lupus erythematosus in Tibet plateau, China [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1004-1008. |
[13] | Yu-bing XIAO,Mu-yao GUO,Xiao-xia ZUO. Immunometabolism and systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1120-1124. |
[14] | Hai-hong YAO,Su-mei TANG,Zhi-min WANG,Xia ZHANG,Xu-yong CHEN,Li GAO,Jing LIU,Yi-jun DAI,Zhao-heng HU,Xue-wu ZHANG,Zhan-guo LI. Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 998-1003. |
[15] | GUO Xiao-yue, SHAO Hui, ZHAO Yang-yu. A case of systemic lupus erythematosus in pregnancy complicated by pulmonary hypertension [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 928-931. |
|